Timothy G. Mant
Reading, Guy's And St. Thomas' NHS Foundation Trust And King's College
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease.
Journal: British journal of clinical pharmacology
Published: October 22, 2018
Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease.
Journal: Hematology reports
Published: February 23, 2018
Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects.
Journal: Psychopharmacology
Published: September 07, 2017
An S-warfarin and AZD1981 interaction: in vitro and clinical pilot data suggest the N-deacetylated amino acid metabolite as the primary perpetrator.
Journal: British journal of clinical pharmacology
Published: March 22, 2016
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial.
Journal: Lancet (London, England)
Published: October 08, 2013
A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulation.
Journal: Thrombosis research
Published: August 20, 2013
A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivity.
Journal: British journal of clinical pharmacology
Published: July 17, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026